Express Scripts Inc. (ESRX)

HEALTH CARE: HEALTH CARE SERVICES
SIC: RETAIL-DRUG STORES AND PROPRIETARY STORES

ONE EXPRESS WAY ST LOUIS, MO 63121

Express Scripts is a pharmacy benefit management (PBM) company. Co.'s PBM services include network claims processing, home delivery services, patient care and direct home delivery to patients, benefit plan design consultation, drug utilization review, formulary management, drug data analysis services, distribution of injectable drugs to patient homes and physician offices, bio-pharma services, and fulfillment of prescriptions to low-income patients. Co.'s emerging markets segment provides distribution of pharmaceuticals and medical supplies to providers and clinics, fertility services, and healthcare administration and implementation of consumer-directed healthcare services.

Data as of 2019-01-11 13:51:45 -0500
Market Cap52.061 Billion Shares Outstanding563.86 Million Avg 30-day Volume
P/E Ratio Dividend Yield0.0 EPS8.58
Price/Sales0.53015 Debt to Equity EBITDA0
Price to Book Value2.53 Forward PE Enterprise Value
Total Cash0 Current Debt Gross Profit0
BETA0.838 52-week High/Low101.73 / 66.93 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from ESRX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 1 1 0.0% (0.0%) (0.0%)
13F shares: 0 0
% Ownership
New Positions:
Increased Positions
Closed Positions
Reduced Positions
Total Calls 0
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ESRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ESRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DELANEY WILLIAM J III

  • Director
0 2018-12-20 0

ROPER WILLIAM L

  • Director
0 2018-12-20 0

BREEN MAURA C

  • Director
0 2018-12-20 0

MYERS WOODROW A JR

  • Director
0 2018-12-20 0

MAC MAHON THOMAS P

  • Director
0 2018-12-20 0

MERGENTHALER FRANK

  • Director
0 2018-12-20 0

LAHOWCHIC NICHOLAS

  • Director
0 2018-12-20 0

STERNBERG SEYMOUR

  • Director
0 2018-12-20 0

STETTIN GLEN D. SR. VP, CLIN. RES. & NEW SOL.

  • Officer
0 2018-12-20 0

MILLER STEVEN B SR. VP & CHIEF MED. OFFICER

  • Officer
0 2018-12-20 0

HOUSTON CHRISTINE EXECUTIVE VICE PRESIDENT

  • Officer
0 2018-12-20 0

WENTWORTH TIMOTHY C PRESIDENT & CEO

  • Officer
  • Director
0 2018-12-20 0

WADE SARA E SR. VP AND CH. HUMAN RES. OFF.

  • Officer
0 2018-12-20 0

QUELLER DAVID A SR. VP, SALES AND ACCOUNT MGMT

  • Officer
0 2018-12-20 0

PALMORE RODERICK A

  • Director
0 2018-12-20 0

HAVEL JAMES M EXECUTIVE VP AND CFO

  • Officer
0 2018-12-20 0

NEVILLE EVERETT EXE VP, STRAT, SUP CHN & SPCLT

  • Officer
0 2018-12-20 0

GRANGER ELDER

  • Director
0 2018-12-20 0

AKINS MARTIN P. SR. VP & GENERAL COUNSEL

  • Officer
0 2018-12-20 0

ANDERSON PHYLLIS S. SR. VP & CH. MARKETING OFFICER

  • Officer
0 2018-12-20 0

SAMPLE NEAL J. EXECUTIVE VP & COO

  • Officer
0 2018-12-20 0

MAZZARELLA KATHLEEN M

  • Director
0 2018-12-20 0

PHILLIPS BRADLEY E VP, CONTROLLER AND CAO

  • Officer
0 2018-12-20 0

SEIZ BRIAN SR. VP, SPECIALTY

  • Officer
0 2018-12-20 0

ARLOTTA JOHN CEO, EVICORE HEALTHCARE

  • Officer
0 2018-12-20 0

GUERRIER RON SR. VP AND CHIEF INFO. OFFICER

  • Officer
0 2018-12-20 0

PAZ GEORGE

  • Director
1,155,931 2018-05-10 0

SLUSSER ERIC EXEC. VP & CFO

  • Officer
37,218 2017-03-08 0

MCGINNIS CHRISTOPHER A VP, CONTROLLER & CH. ACCT. OFF

  • Officer
6,675 2017-03-08 0

FOTSCH DONALD SVP, HOME DEL. & MEM. EXP.

  • Officer
10,360 2016-09-09 0

BENANAV GARY G

  • Director
No longer subject to file 2016-05-04 0

NORTON DAVID A SVP, SPECIALTY & SUPPLY CHAIN

  • Officer
11,160 2016-02-28 0

WIMBERLY GARY SR. VP & CH. INFORMATION OFF.

  • Officer
20,885 2015-06-09 0

EBLING KEITH J. EXEC. VP AND GEN. COUNSEL

  • Officer
70,517 2015-03-04 0

KNIBB CHRISTOPHER K VP & CHIEF ACCOUNTING OFFICER

  • Officer
3,891 2015-03-04 0

PARKER JOHN O

  • Director
27,994 2014-12-05 0

IGNACZAK EDWARD B EVP

  • Officer
69,513 2014-10-29 0

MCNAMEE PATRICK EXEC. VP AND COO

  • Officer
No longer subject to file 2014-03-10 0

SMITH CATHERINE R EXEC. VP & CFO

  • Officer
37,804 2014-03-05 0

HARPER MATTHEW D VP & INTERIM CFO

  • Officer
33,547 2013-11-18 0

SKINNER SAMUEL K

  • Director
78,783 2013-06-12 0

HALL JEFFREY EVP & CHIEF FINANCIAL OFFICER

  • Officer
90,737 2013-05-15 0

ELLIOTT KELLEY CHIEF ACCOUNTING OFFICER

  • Officer
12,164 2012-08-20 0

POTTER MYRTLE S

  • Director
8,775 2012-05-30 0

TOAN BARRETT A

  • Director
No longer subject to file 2011-05-02 0

REY-GIRAUD AGNES PRESIDENT, INTERNATIONAL OPS

  • Officer
91,968 2011-03-02 0

BORELLI FRANK J

  • Director
100,933 2010-05-05 0

HOLMES MICHAEL EVP, STRATEGY, HC & E MKTS

  • Officer
18,318 2010-03-02 0

WALTMAN HOWARD L

  • DIRECTOR EMERITUS
159,251 2009-05-04 0

BOUDREAU THOMAS M EXECUTIVE VP, LAW & STRATEGY

  • Officer
No longer subject to file 2009-04-01 0

NEW YORK LIFE INSURANCE CO

NYLIFE LLC

  • 10% Owner
No longer subject to file 2008-04-22 0

STIFTEN EDWARD J EVP & CFO

  • Officer
78,352 2008-02-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments